Ironwood pharmaceuticals revenue

WebIronwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results February 13, 2024 Ironwood Pharmaceuticals Announces FDA Filing Acceptance and Priority Review of … WebIronwood Pharmaceuticals. 100 Summer Street. Suite 2300. Boston MA 02110. Entrance at the corner of Devonshire St. and Summer St. [email protected]. Tel – …

Ironwood Pharmaceuticals: Contact Details and Business Profile

WebApr 14, 2024 · The business had revenue of $107.20 million during the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of 42.64% and a return on equity of 30.49%. The business's revenue for the quarter was down 8.5% on a year-over-year basis. During the same period last year, the company earned $0.27 EPS. WebApr 12, 2024 · From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $425.09 million. The company’s revenue is forecast to grow by 3.50% over what it did in 2024. A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Ironwood Pharmaceuticals Inc. highland headache relief https://innovaccionpublicidad.com

Ironwood Pharmaceuticals profit, revenue top views

WebIronwood Pharmaceuticals, Inc. is an entrepreneurial pharmaceutical company. ... Total Enterprise Value to Total Revenue (ttm) 3.33. Markets data provided by S&P and by Xignite. WebIronwood Pharmaceuticals is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. One in five Americans suffer from GI diseases, resulting in millions of hospital visits and tens of billions in healthcare costs each year. WebIronwood Pharmaceuticals. Jun 2024 - Present11 months. Boston, Massachusetts, United States. Strategic finance professional at Ironwood Pharmaceuticals, a $500M revenue commercial pharmaceuticals ... highland headland crossword

Insider Sell: Ironwood Pharmaceuticals MarketScreener

Category:Home - Ironwood Pharmaceuticals

Tags:Ironwood pharmaceuticals revenue

Ironwood pharmaceuticals revenue

Ironwood Pharmaceuticals profit, revenue top views

WebApr 15, 2024 · The company had revenue of $107.20 million for the quarter, compared to analyst estimates of $108.23 million. Ironwood Pharmaceuticals had a net margin of … WebFeb 17, 2024 · Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; LINZESS® (linaclotide) Achieves Blockbuster Status as U.S. Net Sales Exceed $1 Billion in 2024 – 2024 total revenue of $414 million, driven primarily by $400 million in …

Ironwood pharmaceuticals revenue

Did you know?

WebSep 30, 2024 · Ironwood Pharmaceuticals revenue is $380.0M annually. After extensive research and analysis, Zippia's data science team found the following key financial … WebNov 6, 2024 · Ironwood (IRWD) delivered earnings and revenue surprises of 64.29% and 10.71%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

WebFeb 16, 2024 · Ironwood , which belongs to the Zacks Medical - Drugs industry, posted revenues of $107.2 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 3.13%. This compares... WebGet the detailed quarterly/annual income statement for Ironwood Pharmaceuticals, Inc. (IRWD). Find out the revenue, expenses and profit or loss over the last fiscal year.

WebFeb 16, 2024 · BOSTON, February 16, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today reported its fourth quarter and full year 2024 results and recent business performance. WebAug 4, 2024 · Ironwood Pharmaceuticals (IRWD) came out with quarterly earnings of $0.21 per share, missing the Zacks Consensus Estimate of $0.31 per share. This compares to …

WebDec 23, 2024 · Ironwood Pharmaceuticals Posts Flat Q4 Adjusted Profit, Revenue Drops; Sets Fiscal 2024.. Transcript : Ironwood Pharmaceuticals, Inc., Q4 2024 Earnings Call, Feb 16, 2.. Analyst Recommendations on IRONWOOD PHARMACEUTICALS, INC. Wells Fargo Adjusts Ironwood Pharmaceuticals' Price Target to $13 from $12, Maintains E..

WebNov 9, 2024 · Ironwood Pharmaceuticals ( NASDAQ:IRWD) Third Quarter 2024 Results Key Financial Results Revenue: US$108.6m (up 4.7% from 3Q 2024). Net income: US$50.3m (down 9.9% from 3Q 2024). Profit... highland healers book 1WebFeb 16, 2024 · Ironwood, which belongs to the Zacks Medical - Drugs industry, posted revenues of $107.2 million for the quarter ended December 2024, missing the Zacks … how is feline histoplasmosis transmittedWebApr 10, 2024 · Ironwood Pharmaceuticals (NASDAQ:IRWD) has a market capitalization of $1.65 billion and generates $410.60 million in revenue each year. The biotechnology … how is feline asthma diagnosedhow is felix lee\u0027s backWebIronwood Pharmaceuticals, headquartered in Boston, Massachusetts, and established in 1998, is a specialty and generic drug manufacturing company specializing in … highland healers book 4WebAs of FY2024, Linzess was by far the most significant contributor to Ironwood's revenues, standing at USD 295.2m relative to total revenue of USD 298.3m. It should be noted that Linzess is not... how is feline herpes diagnosedWebApr 10, 2024 · See how Ironwood Pharmaceuticals compares to its main competitors: Hoffmann-LA Roche Inc has the most employees (101,200). Employees at AstraZeneca earn more than most of the competitors, with an average yearly salary of $112,988. highland healers book 2